Nuvation Bio, Inc. (NUVB)
6.765
+0.12
(+1.88%)
USD |
NYSE |
Sep 02, 13:59
Nuvation Bio Cash from Operations (Annual) : -173.43M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -173.43M |
| December 31, 2024 | -130.41M |
| December 31, 2023 | -68.00M |
| Date | Value |
|---|---|
| December 31, 2022 | -96.11M |
| December 31, 2021 | -68.19M |
| December 31, 2020 | -36.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Bristol Myers Squibb Co. | 14.16B |
| Johnson & Johnson | 24.53B |
| Pfizer Inc. | 11.70B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |